Amante nephew tagged in drugs gunned down in Laguna | Inquirer News

Amante nephew tagged in drugs gunned down in Laguna

/ 04:17 PM August 31, 2019

SAN PEDRO CITY –– Another member of the Amante clan in San Pablo City in Laguna province was gunned down in his home on Saturday.

Gener Amante Jr., 45, also known as “Palapa,” a nephew of former mayor and clan patriarch Vicente Amante, was the second member of the immediate family killed since the government launched its anti-drug campaign.

In a text message to the Inquirer, Laguna police chief Col. Elezar Matta said Gener was gunned down around 8 a.m. in Barangay Sta. Maria Magdalena.

Article continues after this advertisement

According to the police, the victim was sitting outside his home when the gunmen, onboard an unmarked black sports utility vehicle drove by and fired several shots.

FEATURED STORIES

Gener died while being taken to the provincial hospital in the city.

In 2016, President Duterte named the Amantes of San Pablo as among local chief executives involved in the illegal drugs trade.

Article continues after this advertisement

Vicente and his son and incumbent mayor, Loreto, had denied the accusation.

Article continues after this advertisement

But in an earlier Inquirer interview, Vicente said his name was only being dragged because of his brother and nephew’s alleged involvement in drugs.

The following year, in 2017, Vicente’s brother, Damaso, was shot dead by unidentified men. /lzb

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: Drugs, Killing, Laguna, Local news

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.